Annual CFI
-$50.55 M
-$49.18 M-3594.81%
31 December 2023
Summary:
PMV Pharmaceuticals annual cash flow from investing activities is currently -$50.55 million, with the most recent change of -$49.18 million (-3594.81%) on 31 December 2023. During the last 3 years, it has fallen by -$78.46 million (-281.09%). PMVP annual CFI is now -281.09% below its all-time high of $27.91 million, reached on 31 December 2020.PMVP Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
$17.12 M
+$14.80 M+636.93%
30 September 2024
Summary:
PMV Pharmaceuticals quarterly cash flow from investing activities is currently $17.12 million, with the most recent change of +$14.80 million (+636.93%) on 30 September 2024. Over the past year, it has increased by +$50.76 million (+150.89%). PMVP quarterly CFI is now -65.52% below its all-time high of $49.65 million, reached on 31 March 2023.PMVP Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
$43.02 M
+$50.76 M+655.96%
30 September 2024
Summary:
PMV Pharmaceuticals TTM cash flow from investing activities is currently $43.02 million, with the most recent change of +$50.76 million (+655.96%) on 30 September 2024. Over the past year, it has increased by +$67.75 million (+273.93%). PMVP TTM CFI is now -50.61% below its all-time high of $87.10 million, reached on 31 March 2023.PMVP TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PMVP Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -3594.8% | +150.9% | +273.9% |
| 3 y3 years | -281.1% | +2570.3% | +128.4% |
| 5 y5 years | -333.0% | - | - |
PMVP Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -281.1% | +64.8% | -65.5% | +126.8% | -50.6% | +128.4% |
| 5 y | 5 years | -281.1% | +64.8% | -65.5% | +112.2% | -50.6% | +128.4% |
| alltime | all time | -281.1% | +64.8% | -65.5% | +112.2% | -50.6% | +128.4% |
PMV Pharmaceuticals Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $17.12 M(+636.9%) | $43.02 M(-656.0%) |
| June 2024 | - | $2.32 M(-91.1%) | -$7.74 M(-89.5%) |
| Mar 2024 | - | $26.17 M(-1111.1%) | -$74.02 M(+46.5%) |
| Dec 2023 | -$50.55 M(+3594.8%) | -$2.59 M(-92.3%) | -$50.55 M(+104.4%) |
| Sept 2023 | - | -$33.64 M(-47.4%) | -$24.73 M(-164.4%) |
| June 2023 | - | -$63.96 M(-228.8%) | $38.42 M(-55.9%) |
| Mar 2023 | - | $49.65 M(+113.8%) | $87.10 M(-6467.1%) |
| Dec 2022 | -$1.37 M | $23.22 M(-21.3%) | -$1.37 M(-92.0%) |
| Sept 2022 | - | $29.51 M(-293.2%) | -$17.03 M(-63.9%) |
| June 2022 | - | -$15.28 M(-60.6%) | -$47.24 M(+11.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$38.83 M(-613.6%) | -$42.51 M(-70.4%) |
| Dec 2021 | -$143.58 M(-614.4%) | $7.56 M(-1190.8%) | -$143.58 M(-5.0%) |
| Sept 2021 | - | -$693.00 K(-93.4%) | -$151.20 M(+6.1%) |
| June 2021 | - | -$10.55 M(-92.5%) | -$142.47 M(+34.9%) |
| Mar 2021 | - | -$139.90 M(>+9900.0%) | -$105.60 M(-478.4%) |
| Dec 2020 | $27.91 M(+763.9%) | -$57.00 K(-100.7%) | $27.91 M(-0.2%) |
| Sept 2020 | - | $8.04 M(-69.5%) | $27.97 M(+40.3%) |
| June 2020 | - | $26.32 M(-512.2%) | $19.93 M(-412.2%) |
| Mar 2020 | - | -$6.38 M | -$6.38 M |
| Dec 2019 | $3.23 M(-85.1%) | - | - |
| Dec 2018 | $21.69 M | - | - |
FAQ
- What is PMV Pharmaceuticals annual cash flow from investing activities?
- What is the all time high annual CFI for PMV Pharmaceuticals?
- What is PMV Pharmaceuticals annual CFI year-on-year change?
- What is PMV Pharmaceuticals quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for PMV Pharmaceuticals?
- What is PMV Pharmaceuticals quarterly CFI year-on-year change?
- What is PMV Pharmaceuticals TTM cash flow from investing activities?
- What is the all time high TTM CFI for PMV Pharmaceuticals?
- What is PMV Pharmaceuticals TTM CFI year-on-year change?
What is PMV Pharmaceuticals annual cash flow from investing activities?
The current annual CFI of PMVP is -$50.55 M
What is the all time high annual CFI for PMV Pharmaceuticals?
PMV Pharmaceuticals all-time high annual cash flow from investing activities is $27.91 M
What is PMV Pharmaceuticals annual CFI year-on-year change?
Over the past year, PMVP annual cash flow from investing activities has changed by -$49.18 M (-3594.81%)
What is PMV Pharmaceuticals quarterly cash flow from investing activities?
The current quarterly CFI of PMVP is $17.12 M
What is the all time high quarterly CFI for PMV Pharmaceuticals?
PMV Pharmaceuticals all-time high quarterly cash flow from investing activities is $49.65 M
What is PMV Pharmaceuticals quarterly CFI year-on-year change?
Over the past year, PMVP quarterly cash flow from investing activities has changed by +$50.76 M (+150.89%)
What is PMV Pharmaceuticals TTM cash flow from investing activities?
The current TTM CFI of PMVP is $43.02 M
What is the all time high TTM CFI for PMV Pharmaceuticals?
PMV Pharmaceuticals all-time high TTM cash flow from investing activities is $87.10 M
What is PMV Pharmaceuticals TTM CFI year-on-year change?
Over the past year, PMVP TTM cash flow from investing activities has changed by +$67.75 M (+273.93%)